Skip to main content
Moderna, Inc. logo
Moderna, Inc.
  • mRNA Technology
    • The Science of mRNA
    • Our mRNA Platform
    • Research Engine
    • Early Development Engine
    • Intellectual Property
      • Patents
  • COVID-19 Resources
    • USA site for EUA
    • Global Site and Resources
    • Publications and External Resources
  • Pipeline
    • Therapeutic Areas
    • Clinical Trials
    • Modalities
  • Citizenship
  • About Us
    • Leadership
    • Key Milestones
    • Quick Facts
    • Strategic Collaborators
    • New Venture Labs
  • Publications
  • Newsroom
  • Investors
  • Blog
  • Careers
  • Contact Us

Search

  • Publications
  • Newsroom
  • Investors
  • Blog
  • Careers
  • Contact Us
  • mRNA Technology
    • The Science of mRNA
    • Our mRNA Platform
    • Research Engine
    • Early Development Engine
    • Intellectual Property
  • COVID-19 Resources
    • USA site for EUA
    • Global Site and Resources
    • Publications and External Resources
  • Pipeline
    • Therapeutic Areas
    • Clinical Trials
    • Modalities
  • Citizenship
  • About Us
    • Leadership
    • Key Milestones
    • Quick Facts
    • Strategic Collaborators
    • New Venture Labs

Patents

  • The Science of mRNA
  • Our mRNA Platform
  • Research Engine
  • Early Development Engine
  • Intellectual Property

Program Patents

The following are protected by patents in the United States and in foreign jurisdictions for ModernaTx, Inc.

mRNA-1273
COVID-19 VACCINE

US 10,703,789
US 10,702,600
US 10,577,403
US 10,442,756
US 10,266,485
US 10,064,959
US 9,868,692

  • mRNA Technology
  • COVID-19 Resources
  • Pipeline
  • Citizenship
  • About Us
  • Publications
  • Newsroom
  • Investors
  • Blog
  • Careers
  • Contact Us
  • Facebook
  • Twitter
  • Youtube
  • LinkedIn
  • © 2020 Moderna, Inc.
  • Privacy Policy
  • Join our Mailing List
  • Terms Of Use